{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:27:23Z","timestamp":1791170843245,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81070956"],"award-info":[{"award-number":["81070956"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81371414"],"award-info":[{"award-number":["81371414"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.jns.2015.03.022","type":"journal-article","created":{"date-parts":[[2015,4,20]],"date-time":"2015-04-20T23:46:58Z","timestamp":1429573618000},"page":"28-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Multitarget intervention of Fasudil in the neuroprotection of dopaminergic neurons in MPTP-mouse model of Parkinson's disease"],"prefix":"10.1016","volume":"353","author":[{"given":"Yong-fei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-ying","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cun-gen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-guo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2015.03.022_bb0005","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2015.03.022_bb0010","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0896-6273(00)81175-7","article-title":"A critical role for a Rho-associated kinase, p160ROCK, in determining axon outgrowth in mammalian CNS neurons","volume":"26","author":"Bito","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.jns.2015.03.022_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2014.05.021","article-title":"Inhibition of the microglial response is essential for the neuroprotective effects of Rho-kinase inhibitors on MPTP-induced dopaminergic cell death","volume":"85","author":"Borrajo","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jns.2015.03.022_bb0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mcn.2011.08.008","article-title":"Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP\/PKA\/ROCK-dependent manner","volume":"49","author":"Brown","year":"2012","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.jns.2015.03.022_bb0025","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1517\/13543784.2013.778242","article-title":"Fasudil and its analogs: a new powerful weapon in the long war against central nervous system disorders?","volume":"22","author":"Chen","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jns.2015.03.022_bb0030","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1440-1789.2009.01077.x","article-title":"Synergistic effects of bone marrow stromal cells and a Rho kinase (ROCK) inhibitor, Fasudil on axon regeneration in rat spinal cord injury","volume":"30","author":"Chiba","year":"2010","journal-title":"Neuropathology"},{"key":"10.1016\/j.jns.2015.03.022_bb0035","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.nbd.2005.11.007","article-title":"Isoprenoids and Alzheimer's disease: a complex relationship","volume":"22","author":"Cole","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jns.2015.03.022_bb0040","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.jns.2015.03.022_bb0045","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.bbi.2009.05.002","article-title":"Rho kinase inhibitor Fasudil induces neuroprotection and neurogenesis partially through astrocyte-derived G-CSF","volume":"23","author":"Ding","year":"2009","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jns.2015.03.022_bb0050","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.03.022_bb0055","doi-asserted-by":"crossref","first-page":"15266","DOI":"10.1523\/JNEUROSCI.4650-09.2009","article-title":"Rho-associated kinase II (ROCKII) limits axonal growth after trauma within the adult mouse spinal cord","volume":"29","author":"Duffy","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2015.03.022_bb0060","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1189\/jlb.0406249","article-title":"Biochemical and functional characterization of three activated macrophage populations","volume":"80","author":"Edwards","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jns.2015.03.022_bb0065","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200103083441002","article-title":"Transplantation of embryonic dopamine neurons for severe Parkinson's disease","volume":"344","author":"Freed","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jns.2015.03.022_bb0070","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.neurobiolaging.2011.10.020","article-title":"Ko L-w, Kuriyama M, Pitavastatin decreases tau levels via the inactivation of Rho\/ROCK","volume":"33","author":"Hamano","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jns.2015.03.022_bb0075","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0306-4522(95)00578-1","article-title":"Nitric oxide synthase and neuronal vulnerability in Parkinson's disease","volume":"72","author":"Hunot","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2015.03.022_bb0080","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1074\/jbc.273.5.2489","article-title":"p160 RhoA-binding kinase ROK\u03b1 induces neurite retraction","volume":"273","author":"Katoh","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2015.03.022_bb0085","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1523\/JNEUROSCI.20-16-06309.2000","article-title":"Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia","volume":"20","author":"Kim","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2015.03.022_bb0090","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jnutbio.2014.03.006","article-title":"Naringin protects the nigrostriatal dopaminergic projection through induction of GDNF in a neurotoxin model of Parkinson's disease","volume":"25","author":"Leem","year":"2014","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.jns.2015.03.022_bb0095","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.1523\/JNEUROSCI.19-17-07537.1999","article-title":"Inactivation of Rho signaling pathway promotes CNS axon regeneration","volume":"19","author":"Lehmann","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2015.03.022_bb0100","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1159\/000356606","article-title":"GSK-3\u03b2 inhibition attenuates LPS-induced death but aggravates radiation-induced death via down-regulation of IL-6","volume":"32","author":"Li","year":"2013","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jns.2015.03.022_bb0105","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.bcp.2008.07.017","article-title":"Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis","volume":"76","author":"Li","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jns.2015.03.022_bb0110","doi-asserted-by":"crossref","first-page":"e54841","DOI":"10.1371\/journal.pone.0054841","article-title":"Targeting the shift from M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice treated with Fasudil","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2015.03.022_bb0115","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bbamcr.2008.01.002","article-title":"NF-kappaB\/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK","volume":"1783","author":"Liu","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jns.2015.03.022_bb0120","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nrm2679","article-title":"The trip of the tip: understanding the growth cone machinery","volume":"10","author":"Lowery","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jns.2015.03.022_bb0125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-0270(96)02211-X","article-title":"Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion","volume":"73","author":"Matsuura","year":"1997","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.jns.2015.03.022_bb0130","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA\u2010DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.03.022_bb0135","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","article-title":"Glial reactions in Parkinson's disease","volume":"23","author":"McGeer","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2015.03.022_bb0140","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.exer.2012.08.007","article-title":"Retinal arteriolar responses to acute severe elevation in systemic blood pressure in cats: role of endothelium-derived factors","volume":"103","author":"Nakabayashi","year":"2012","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jns.2015.03.022_bb0145","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1357-2725(01)00167-4","article-title":"The role of Rho GTPases and associated kinases in regulating neurite outgrowth","volume":"34","author":"Nikolic","year":"2002","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jns.2015.03.022_bb0150","first-page":"435","article-title":"A simple quantitative bradykinesia test in MPTP-treated mice","volume":"50","author":"Ogawa","year":"1985","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1016\/j.jns.2015.03.022_bb0155","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1212\/WNL.0b013e3182a55ea5","article-title":"Benefits of putaminal GDNF infusion in Parkinson disease are maintained after GDNF cessation","volume":"81","author":"Patel","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2015.03.022_bb0160","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/674987","article-title":"Neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets","volume":"2014","author":"Sandireddy","year":"2014","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.jns.2015.03.022_bb0165","doi-asserted-by":"crossref","first-page":"E806","DOI":"10.1152\/ajpendo.00206.2012","article-title":"Rho-kinase inhibition improves vasodilator responsiveness during hyperinsulinemia in the metabolic syndrome","volume":"303","author":"Schinzari","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jns.2015.03.022_bb0170","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/mds.10619","article-title":"Parkinson's prevalence estimated by a state registry","volume":"19","author":"Strickland","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2015.03.022_bb0175","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1093\/brain\/aws254","article-title":"Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease","volume":"135","author":"T\u00f6nges","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jns.2015.03.022_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2011.00039","article-title":"ROCKing regeneration: Rho kinase inhibition as molecular target for neurorestoration","volume":"4","author":"T\u00f6nges","year":"2011","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.jns.2015.03.022_bb0185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jbt.21464","article-title":"Pesticides, microglial NOX2, and Parkinson's disease","volume":"27","author":"Taetzsch","year":"2013","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.jns.2015.03.022_bb0190","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/NEN.0000000000000095","article-title":"Rho kinase inhibition by Fasudil in the striatal 6-hydroxydopamine lesion mouse model of Parkinson disease","volume":"73","author":"Tatenhorst","year":"2014","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jns.2015.03.022_bb0195","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.nbd.2014.01.009","article-title":"Pharmacologically controlled, discontinuous GDNF gene therapy restores motor function in a rat model of Parkinson's disease","volume":"65","author":"Tereshchenko","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jns.2015.03.022_bb0200","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/jnc.12633","article-title":"DJ\u20101 deficiency triggers microglia sensitivity to dopamine toward a pro\u2010inflammatory phenotype that is attenuated by rasagiline","volume":"129","author":"Trudler","year":"2014","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2015.03.022_bb0205","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.nbd.2012.04.010","article-title":"Involvement of microglial RhoA\/Rho-kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors","volume":"47","author":"Villar-Cheda","year":"2012","journal-title":"Neurobiol Dis"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X15001537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X15001537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T17:20:14Z","timestamp":1566580814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X15001537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":41,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0022510X15001537"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2015.03.022","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multitarget intervention of Fasudil in the neuroprotection of dopaminergic neurons in MPTP-mouse model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2015.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}